Latent change-on-change between amyloid accumulation and cognitive decline

Alzheimers Dement. 2024 Dec;20(12):8728-8738. doi: 10.1002/alz.14326. Epub 2024 Oct 29.

Abstract

Introduction: While the influence of cross-sectional β-amyloid (Aβ) on longitudinal changes in cognition is well established, longitudinal change-on-change between Aβ and cognition is less explored.

Methods: A series of bivariate latent change score models (LCSM) examined the relationship between changes in 11C-Pittsburgh Compound-B (PiB) positron emission tomography (PET) and the Preclinical Alzheimer's Cognitive Composite-5 (PACC-5) while adjusting for covariates, including cross-sectional medial temporal lobe (MTL) tau-PET burden. We selected 352 clinically normal older participants with up to 9 years of PiB-PET and PACC-5 data from the Harvard Aging Brain Study (HABS).

Results: Aβ accumulation was associated with subsequent cognitive decline beyond the effects of cross-sectional Aβ burden. Within this model including covariates such as age, sex, and apolipoprotein ε4 (APOEε4) status, we found no evidence supporting previously published associations between cross-sectional tau-PET and cognitive intercept/slope.

Discussion: Short-term Aβ changes are significantly associated with cognitive decline in clinically normal older adults and may eclipse the effect of cross-sectional Aβ and MTL tau.

Highlights: Aβ accumulation is associated with subsequent cognitive decline. High Aβ burden is not the sole metric signaling impending cognitive decline. Contrary to prior work, MTL tau-PET and cognition were not associated in our models. Models of bivariate latent Aβ and cognitive change may eclipse the effects of MTL tau.

Keywords: Alzheimer's disease; amyloid accumulation; change‐on‐change; cognitive decline; latent change score models; structural equation models.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnostic imaging
  • Alzheimer Disease / metabolism
  • Amyloid beta-Peptides* / metabolism
  • Aniline Compounds*
  • Brain / diagnostic imaging
  • Brain / metabolism
  • Cognitive Dysfunction* / diagnostic imaging
  • Cognitive Dysfunction* / metabolism
  • Cross-Sectional Studies
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Neuropsychological Tests / statistics & numerical data
  • Positron-Emission Tomography*
  • Temporal Lobe / diagnostic imaging
  • Temporal Lobe / metabolism
  • Thiazoles
  • tau Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • Aniline Compounds
  • Thiazoles
  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • tau Proteins